Optimization of the IL-8 Luc assay as an in vitro test for skin sensitization

Toxicology in Vitro

Volumn 29, Issue 7, 2015, Pages 1816-1830

  Kimura, Yutaka ^a,b   Fujimura, Chizu ^a,b   Ito, Yumiko ^a,b   Takahashi, Toshiya ^a,b   Nakajima, Yoshihiro ^a,b   Ohmiya, Yoshihiro ^a,b   Aiba, Setsuya ^a,b  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Alternative method; Contact dermatitis; Luciferase assay; Sensitization test; Skin sensitization

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ACETYLCYSTEINE; ANILINE; BENZOCAINE; CINNAMALDEHYDE; CINNAMYL ALCOHOL; DETERGENT; ESTRAGOLE; ETHYLENE GLYCOL DIMETHACRYLATE; ETHYLENEDIAMINE; EUGENOL; GLYCEROL; GLYOXAL; INTERLEUKIN 8; ISOEUGENOL; LACTIC ACID; LUCIFERASE; OXAZOLONE; PENICILLIN G; PHTHALIC ANHYDRIDE; PYRIDINE; SALICYLIC ACID; THIRAM; TRIMELLITIC ANHYDRIDE; TUBERCULIN; ALLERGEN; HAPTEN;

ARTICLE; CONTROLLED STUDY; DIRECT PEPTIDE REACTIVITY ASSAY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INCUBATION TIME; INTERLEUKIN 8 LUCIFERASE ASSAY; LUCIFERASE ASSAY; MEASUREMENT ACCURACY; SENSITIVITY AND SPECIFICITY; SKIN SENSITIZATION; GENETICS; SKIN TEST; TUMOR CELL LINE;

ALLERGENS; CELL LINE, TUMOR; HAPTENS; HUMANS; INTERLEUKIN-8; LUCIFERASES; SKIN TESTS;

EID: 84938125457     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.07.006     Document Type: Article

References (52)

1. Ashikaga T., Sakaguchi H., Sono S., Kosaka N., Ishikawa M., Nukada Y., Miyazawa M., Ito Y., Nishiyama N., Itagaki H. A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). ATLA 2010, 38:275-284.
2. Ashikaga T., Yoshida Y., Hirota M., Yoneyama K., Itagaki H., Sakaguchi H., Miyazawa M., Ito Y., Suzuki H., Toyoda H. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. Toxicol. In Vitro 2006, 20:767-773.
3. Basketter D.A., Alepee N., Ashikaga T., Barroso J., Gilmour N., Goebel C., Hibatallah J., Hoffmann S., Kern P., Martinozzi-Teissier S., Maxwell G., Reisinger K., Sakaguchi H., Schepky A., Tailhardat M., Templier M. Categorization of chemicals according to their relative human skin sensitizing potency. Dermatitis 2014, 25:11-21.
4. Bauch C., Kolle S.N., Ramirez T., Eltze T., Fabian E., Mehling A., Teubner W., van Ravenzwaay B., Landsiedel R. Putting the parts together: combining in vitro methods to test for skin sensitizing potentials. Regul. Toxicol. Pharmacol. 2012, 63:489-504.
5. Casati S., Aeby P., Kimber I., Maxwell G., Ovigne J.M., Roggen E., Rovida C., Tosti L., Basketter D. Selection of chemicals for the development and evaluation of in vitro methods for skin sensitisation testing. ATLA 2009, 37:305-312.
6. Coquette A., Berna N., Vandenbosch A., Rosdy M., Poumay Y. Differential expression and release of cytokines by an in vitro reconstructed human epidermis following exposure to skin irritant and sensitizing chemicals. Toxicol. In Vitro 1999, 13:867-877.
7. Corazza M., Lauriola M.M., Zappaterra M., Bianchi A., Virgili A. Surfactants, skin cleansing protagonists. J. Eur. Acad. Dermatol. Venereol. 2010, 24:1-6.
8. Divkovic M., Pease C.K., Gerberick G.F., Basketter D.A. Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact Dermatitis 2005, 53:189-200.
9. Edwards D.R., Denhardt D.T. A study of mitochondrial and nuclear transcription with cloned cDNA probes. Changes in the relative abundance of mitochondrial transcripts after stimulation of quiescent mouse fibroblasts. Exp. Cell Res. 1985, 157:127-143.
10. Emter R., Ellis G., Natsch A. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol. Appl. Pharmacol. 2010, 245:281-290.
11. Feijoo E., Alfaro C., Mazzolini G., Serra P., Penuelas I., Arina A., Huarte E., Tirapu I., Palencia B., Murillo O., Ruiz J., Sangro B., Richter J.A., Prieto J., Melero I. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int. J. Cancer 2005, 116:275-281.
12. Gerberick G.F., Ryan C.A., Kern P.S., Schlatter H., Dearman R.J., Kimber I., Patlewicz G.Y., Basketter D.A. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 2005, 16:157-202.
13. Gerberick G.F., Vassallo J.D., Bailey R.E., Chaney J.G., Morrall S.W., Lepoittevin J.P. Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 2004, 81:332-343.
14. Gerberick G.F., Vassallo J.D., Foertsch L.M., Price B.B., Chaney J.G., Lepoittevin J.P. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol. Sci. 2007, 97:417-427.
15. Gouwy M., Struyf S., Leutenez L., Portner N., Sozzani S., Van Damme J. Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells. Immunobiology 2014, 219:218-229.
16. Holland R., Fishbein J.C. Chemistry of the cysteine sensors in Kelch-like ECH-associated protein 1. Antioxid. Redox Signal. 2010, 13:1749-1761.
17. Hopkins J.E., Naisbitt D.J., Kitteringham N.R., Dearman R.J., Kimber I., Park B.K. Selective haptenation of cellular or extracellular protein by chemical allergens: association with cytokine polarization. Chem. Res. Toxicol. 2005, 18:375-381.
18. ICCVAM, 2011. ICCVAM Test Method Evaluation Report: Usefulness and Limitations of the Murine Local Lymph Node Assay for Potency Categorization of Chemicals Causing Allergic Contact Dermatitis in Humans. http://iccvam.niehs.nih.gov/docs/immunotox_docs/LLNA-pot/TMER.pdf.
19. Itoh K., Mimura J., Yamamoto M. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid. Redox Signal. 2010, 13:1665-1678.
20. Jaworska J., Dancik Y., Kern P., Gerberick F., Natsch A. Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice. J. Appl. Toxicol. 2013, 33:1353-1364.
21. Jaworska J., Harol A., Kern P.S., Gerberick G.F. Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept case. ALTEX 2011, 28:211-225.
22. Jimenez F., Quinones M.P., Martinez H.G., Estrada C.A., Clark K., Garavito E., Ibarra J., Melby P.C., Ahuja S.S. CCR2 plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-kappa B. J. Immunol. 2010, 184:5571-5581.
23. Jowsey I.R., Basketter D.A., Westmoreland C., Kimber I. A future approach to measuring relative skin sensitising potency: a proposal. J. Appl. Toxicol. 2006, 26:341-350.
24. Leonard E.J., Skeel A., Yoshimura T., Noer K., Kutvirt S., Van Epps D. Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. J. Immunol. 1990, 144:1323-1330.
25. Marchese A., Heiber M., Nguyen T., Heng H.H., Saldivia V.R., Cheng R., Murphy P.M., Tsui L.C., Shi X., Gregor P., et al. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics 1995, 29:335-344.
26. Mitjans M., Viviani B., Lucchi L., Galli C.L., Marinovich M., Corsini E. Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naive THP-1 cells. Toxicol. In Vitro 2008, 22:386-395.
27. Mitjans M., Galbiati V., Lucchi L., Viviani B., Marinovich M., Galli C.L., Corsini E. Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency in vitro. Toxicol. In Vitro 2010, 24:1803-1809.
28. Mori R., Wang Q., Danenberg K.D., Pinski J.K., Danenberg P.V. Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer. Prostate 2008, 68:1555-1560.
29. Murphy P.M., Tiffany H.L. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991, 253:1280-1283.
30. Nakajima Y., Kimura T., Sugata K., Enomoto T., Asakawa A., Kubota H., Ikeda M., Ohmiya Y. Multicolor luciferase assay system: one-step monitoring of multiple gene expressions with a single substrate. Biotechniques 2005, 38:891-894.
31. Natsch A., Emter R., Ellis G. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing. Toxicol. Sci. 2009, 107:106-121.
32. Natsuaki Y., Egawa G., Nakamizo S., Ono S., Hanakawa S., Okada T., Kusuba N., Otsuka A., Kitoh A., Honda T., Nakajima S., Tsuchiya S., Sugimoto Y., Ishii K.J., Tsutsui H., Yagita H., Iwakura Y., Kubo M., Ng L.G., Hashimoto T., Fuentes J., Guttman-Yassky E., Miyachi Y., Kabashima K. Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin. Nat. Immunol. 2014, 15:1064-1069.
33. Noguchi T., Ikeda M., Ohmiya Y., Nakajima Y. Simultaneous monitoring of independent gene expression patterns in two types of cocultured fibroblasts with different color-emitting luciferases. BMC Biotechnol. 2008, 8:40.
34. Nukada Y., Miyazawa M., Kosaka N., Ito Y., Sakaguchi H., Nishiyama N. Production of IL-8 in THP-1 cells following contact allergen stimulation via mitogen-activated protein kinase activation or tumor necrosis factor-alpha production. J. Toxicol. Sci. 2008, 33:175-185.
35. Nukada Y., Ashikaga T., Miyazawa M., Hirota M., Sakaguchi H., Sasa H., Nishiyama N. Prediction of skin sensitization potency of chemicals by human Cell Line Activation Test (h-CLAT) and an attempt at classifying skin sensitization potency. Toxicol. In Vitro 2012, 26:1150-1160.
36. Nukada Y., Miyazawa M., Kazutoshi S., Sakaguchi H., Nishiyama N. Data integration of non-animal tests for the development of a test battery to predict the skin sensitizing potential and potency of chemicals. Toxicol. In Vitro 2013, 27:609-618.
37. OECD, 2012. The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins, Part 1: Scientific Evidence. OECD Environment, Health and Safety Publications, Series on Testing and Assessment No. 168.
38. Piroird C., Ovigne J.M., Rousset F., Martinozzi-Teissier S., Gomes C., Cotovio J., Alepee N. The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization. Toxicol. In Vitro 2015, 29:901-916.
39. Python F., Goebel C., Aeby P. Assessment of the U937 cell line for the detection of contact allergens. Toxicol. Appl. Pharmacol. 2007, 220:113-124.
40. Saito K., Miyazawa M., Nukada Y., Sakaguchi H., Nishiyama N. Development of an in vitro skin sensitization test based on ROS production in THP-1 cells. Toxicol. In Vitro 2013, 27:857-863.
41. Saito R., Hirakawa S., Ohara H., Yasuda M., Yamazaki T., Nishii S., Aiba S. Nickel differentially regulates NFAT and NF-kappaB activation in T cell signaling. Toxicol. Appl. Pharmacol. 2011, 254:245-255.
42. Sakaguchi H., Ashikaga T., Miyazawa M., Yoshida Y., Ito Y., Yoneyama K., Hirota M., Itagaki H., Toyoda H., Suzuki H. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. Toxicol. In Vitro 2006, 20:774-784.
43. Sebok K., Woodside D., Al-Aoukaty A., Ho A.D., Gluck S., Maghazachi A.A. IL-8 induces the locomotion of human IL-2-activated natural killer cells. Involvement of a guanine nucleotide binding (Go) protein. J. Immunol. 1993, 150:1524-1534.
44. Singha B., Gatla H.R., Manna S., Chang T.P., Sanacora S., Poltoratsky V., Vancura A., Vancurova I. Proteasome inhibition increases recruitment of IkappaB kinase beta (IKKbeta), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells. J. Biol. Chem. 2014, 289:2687-2700.
45. Takahashi T., Kimura Y., Saito R., Nakajima Y., Ohmiya Y., Yamasaki K., Aiba S. An in vitro test to screen skin sensitizers using a stable THP-1-derived IL-8 reporter cell line, THP-G8. Toxicol. Sci. 2011, 124:359-369.
46. Takenouchi O., Miyazawa M., Saito K., Ashikaga T., Sakaguchi H. Predictive performance of the human Cell Line Activation Test (h-CLAT) for lipophilic chemicals with high octanol-water partition coefficients. J. Toxicol. Sci. 2013, 38:599-609.
47. Toebak M.J., Pohlmann P.R., Sampat-Sardjoepersad S.C., von Blomberg B.M., Bruynzeel D.P., Scheper R.J., Rustemeyer T., Gibbs S. CXCL8 secretion by dendritic cells predicts contact allergens from irritants. Toxicol. In Vitro 2006, 20:117-124.
48. Trompezinski S., Migdal C., Tailhardat M., Le Varlet B., Courtellemont P., Haftek M., Serres M. Characterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways. Toxicol. Appl. Pharmacol. 2008, 230:397-406.
49. Tsujita-Inoue K., Hirota M., Ashikaga T., Atobe T., Kouzuki H., Aiba S. Skin sensitization risk assessment model using artificial neural network analysis of data from multiple in vitro assays. Toxicol. In Vitro 2014, 28:626-639.
50. White K.J., Maffei V.J., Newton-West M., Swerlick R.A. Irritant activation of epithelial cells is mediated via protease-dependent EGFR activation. J. Invest. Dermatol. 2011, 131:435-442.
51. Winer J., Jung C.K., Shackel I., Williams P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 1999, 270:41-49.
52. Zhang X., Chen X., Song H., Chen H.Z., Rovin B.H. Activation of the Nrf2/antioxidant response pathway increases IL-8 expression. Eur. J. Immunol. 2005, 35:3258-3267.